Reports

BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses

Science  23 Jan 1976:
Vol. 191, Issue 4224, pp. 299-301
DOI: 10.1126/science.191.4224.299

Abstract

The quantitative relationship between bacillus Calmette-Guerin (BCG) and tumor cells which are optimal for suppressing the growth of tumor cells in BCG-tumor cell mixtures are detrimental to the development of a sustained, systemic tumor rejection immunity in the LSTRA murine leukemia.

Related Content